Ameriprise’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.07M | Sell |
211,388
-2,347
| -1% | -$11.8K | ﹤0.01% | 3220 |
|
|
2025
Q1 | $1.39M | Sell |
213,735
-5,437
| -2% | -$35.2K | ﹤0.01% | 3049 |
|
|
2024
Q4 | $1.61M | Sell |
219,172
-48,242
| -18% | -$354K | ﹤0.01% | 3016 |
|
|
2024
Q3 | $2M | Sell |
267,414
-40,933
| -13% | -$307K | ﹤0.01% | 2910 |
|
|
2024
Q2 | $2.74M | Sell |
308,347
-14,229
| -4% | -$127K | ﹤0.01% | 2716 |
|
|
2024
Q1 | $3.27M | Buy |
322,576
+9,824
| +3% | +$99.5K | ﹤0.01% | 2621 |
|
|
2023
Q4 | $3.15M | Buy |
312,752
+1,697
| +0.5% | +$17.1K | ﹤0.01% | 2637 |
|
|
2023
Q3 | $2.91M | Buy |
311,055
+34,902
| +13% | +$327K | ﹤0.01% | 2640 |
|
|
2023
Q2 | $6.77M | Sell |
276,153
-27,386
| -9% | -$672K | ﹤0.01% | 2111 |
|
|
2023
Q1 | $7.06M | Sell |
303,539
-3,386
| -1% | -$78.8K | ﹤0.01% | 2058 |
|
|
2022
Q4 | $7.77M | Sell |
306,925
-270,452
| -47% | -$6.84M | ﹤0.01% | 1958 |
|
|
2022
Q3 | $11.1M | Buy |
577,377
+261,479
| +83% | +$5.04M | ﹤0.01% | 1587 |
|
|
2022
Q2 | $8.05M | Buy |
315,898
+298,022
| +1,667% | +$7.59M | ﹤0.01% | 1912 |
|
|
2022
Q1 | $459K | Buy |
17,876
+3,644
| +26% | +$93.6K | ﹤0.01% | 3517 |
|
|
2021
Q4 | $596K | Buy |
14,232
+880
| +7% | +$36.9K | ﹤0.01% | 3449 |
|
|
2021
Q3 | $581K | Sell |
13,352
-200
| -1% | -$8.7K | ﹤0.01% | 3349 |
|
|
2021
Q2 | $641K | Buy |
13,552
+105
| +0.8% | +$4.97K | ﹤0.01% | 3369 |
|
|
2021
Q1 | $689K | Buy |
+13,447
| New | +$689K | ﹤0.01% | 3288 |
|